» Articles » PMID: 35056616

Food Additives, a Key Environmental Factor in the Development of IBD Through Gut Dysbiosis

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Jan 21
PMID 35056616
Authors
Affiliations
Soon will be listed here.
Abstract

Diet is a key environmental factor in inflammatory bowel disease (IBD) and, at the same time, represents one of the most promising therapies for IBD. Our daily diet often contains food additives present in numerous processed foods and even in dietary supplements. Recently, researchers and national authorities have been paying much attention to their toxicity and effects on gut microbiota and health. This review aims to gather the latest data focusing on the potential role of food additives in the pathogenesis of IBDs through gut microbiota modulation. Some artificial emulsifiers and sweeteners can induce the dysbiosis associated with an alteration of the intestinal barrier, an activation of chronic inflammation, and abnormal immune response accelerating the onset of IBD. Even if most of these results are retrieved from in vivo and in vitro studies, many artificial food additives can represent a potential hidden driver of gut chronic inflammation through gut microbiota alterations, especially in a population with IBD predisposition. In this context, pending the confirmation of these results by large human studies, it would be advisable that IBD patients avoid the consumption of processed food containing artificial food additives and follow a personalized nutritional therapy prescribed by a clinical nutritionist.

Citing Articles

The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier.

Rondinella D, Raoul P, Valeriani E, Venturini I, Cintoni M, Severino A Nutrients. 2025; 17(5).

PMID: 40077728 PMC: 11901572. DOI: 10.3390/nu17050859.


Additives in foods marketed to children in Uruguay, an emerging Latin American country.

Alcaire F, Gimenez A, Ares G J Nutr Sci. 2025; 14:e6.

PMID: 39943940 PMC: 11811850. DOI: 10.1017/jns.2024.98.


Lower Semen Quality Among Men in the Modern Era-Is There a Role for Diet and the Microbiome?.

Magoutas K, Leathersich S, Hart R, Ireland D, Walls M, Payne M Microorganisms. 2025; 13(1).

PMID: 39858914 PMC: 11768045. DOI: 10.3390/microorganisms13010147.


Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective.

Qin L, Lv W Nutr J. 2025; 24(1):12.

PMID: 39849464 PMC: 11755847. DOI: 10.1186/s12937-025-01075-y.


Amlodipine Attenuates Carrageenan-induced Oxidative Stress Targeting Transsynaptic 
Neuronal Damage by Promoting Survival of 
Retinal Ganglion Cells in Adult Zebrafish 
(.

Nanda A, Aparna S, Sahoo R, Patri M Ann Neurosci. 2024; :09727531241246671.

PMID: 39544651 PMC: 11559947. DOI: 10.1177/09727531241246671.


References
1.
Bian X, Chi L, Gao B, Tu P, Ru H, Lu K . Gut Microbiome Response to Sucralose and Its Potential Role in Inducing Liver Inflammation in Mice. Front Physiol. 2017; 8:487. PMC: 5522834. DOI: 10.3389/fphys.2017.00487. View

2.
Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H . Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?. World J Gastroenterol. 2021; 27(23):3317-3326. PMC: 8218353. DOI: 10.3748/wjg.v27.i23.3317. View

3.
Birchenough G, Johansson M, Gustafsson J, Bergstrom J, Hansson G . New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015; 8(4):712-9. PMC: 4631840. DOI: 10.1038/mi.2015.32. View

4.
Uebanso T, Ohnishi A, Kitayama R, Yoshimoto A, Nakahashi M, Shimohata T . Effects of Low-Dose Non-Caloric Sweetener Consumption on Gut Microbiota in Mice. Nutrients. 2017; 9(6). PMC: 5490539. DOI: 10.3390/nu9060560. View

5.
Bloemendaal A, Buchs N, George B, Guy R . Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery. 2016; 159(5):1237-48. DOI: 10.1016/j.surg.2016.01.014. View